Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

31. Januar 2013 08:00 ET | Quelle: Kane Biotech Inc.

This Smile Brought To You By Science-StrixNB(TM)

WINNIPEG, MANITOBA--(Marketwire - Jan. 31, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE), will launch its marketing field test for StrixNB, its revolutionary new pet oral care product, in...
14. Dezember 2012 13:31 ET | Quelle: Kane Biotech Inc.

Kane Biotech Announces Closing of Private Placement Offering

WINNIPEG, MANITOBA--(Marketwire - Dec. 14, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced closing of the Corporation's previously announced non-brokered...
28. November 2012 08:30 ET | Quelle: Kane Biotech Inc.

Kane Biotech Appoints Dr. Arvind K. Joshi, M.D. to the Board of Directors

WINNIPEG, MANITOBA--(Marketwire - Nov. 28, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...
27. November 2012 08:30 ET | Quelle: Kane Biotech Inc.

Kane Biotech Receives Health Canada Approval for KBI Disinfectant Label Expansion

WINNIPEG, MANITOBA--(Marketwire - Nov. 27, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
20. November 2012 08:30 ET | Quelle: Kane Biotech Inc.

Kane Biotech Prepares to Launch StrixNB(TM) Pet Oral Care Product

WINNIPEG, MANITOBA--(Marketwire - Nov. 20, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
15. November 2012 08:30 ET | Quelle: Kane Biotech Inc.

Kane Biotech Successfully Completes Veterinary Clinic Testing of StrixNB(TM)

WINNIPEG, MANITOBA--(Marketwire - Nov. 15, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
14. November 2012 08:30 ET | Quelle: Kane Biotech Inc.

Kane Biotech Announces Private Placement Offering

WINNIPEG, MANITOBA--(Marketwire - Nov. 14, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced the intention of the Corporation to undertake a non-brokered...
06. November 2012 08:29 ET | Quelle: Kane Biotech Inc.

Kane Biotech Issued New Patent in Australia for Aledex(R)

WINNIPEG, MANITOBA--(Marketwire - Nov. 6, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
25. Oktober 2012 08:30 ET | Quelle: Kane Biotech Inc.

Kane Biotech and Avmor Sign Licensing Agreement for KBI Disinfectant in Canada

WINNIPEG, MANITOBA--(Marketwire - Oct. 25, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
16. Oktober 2012 08:30 ET | Quelle: Kane Biotech Inc.

Kane Biotech Issued New Patent in Japan for DispersinB(R)

WINNIPEG, MANITOBA--(Marketwire - Oct. 16, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

Vorherige Seite

Nächste Seite